PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 113 filers reported holding PTC THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,551 | -51.2% | 7,075 | -11.4% | 0.10% | -50.3% |
| Q2 2023 | $324,913 | -13.8% | 7,989 | +2.6% | 0.19% | -6.8% |
| Q1 2023 | $377,057 | +29.2% | 7,784 | +1.8% | 0.21% | +36.2% |
| Q4 2022 | $291,924 | -36.7% | 7,648 | -16.7% | 0.15% | -17.4% |
| Q3 2022 | $461,000 | +27.3% | 9,177 | +1.5% | 0.18% | +37.3% |
| Q2 2022 | $362,000 | -3.2% | 9,043 | -9.9% | 0.13% | -19.8% |
| Q1 2022 | $374,000 | -6.5% | 10,034 | 0.0% | 0.17% | +10.6% |
| Q4 2021 | $400,000 | +3.1% | 10,034 | -3.7% | 0.15% | -11.7% |
| Q3 2021 | $388,000 | -19.3% | 10,416 | -8.4% | 0.17% | -13.6% |
| Q2 2021 | $481,000 | +7.1% | 11,368 | +20.0% | 0.20% | +4.2% |
| Q1 2021 | $449,000 | -20.2% | 9,476 | +2.8% | 0.19% | -18.8% |
| Q4 2020 | $563,000 | +1.4% | 9,220 | -22.3% | 0.23% | -19.6% |
| Q3 2020 | $555,000 | +0.7% | 11,863 | +9.2% | 0.29% | +11.5% |
| Q2 2020 | $551,000 | +1.3% | 10,864 | -10.9% | 0.26% | +16.5% |
| Q1 2020 | $544,000 | -14.3% | 12,197 | -7.8% | 0.22% | +115.4% |
| Q4 2019 | $635,000 | +198.1% | 13,226 | +109.7% | 0.10% | +141.9% |
| Q3 2019 | $213,000 | -29.0% | 6,308 | -5.3% | 0.04% | -31.7% |
| Q2 2019 | $300,000 | +0.3% | 6,660 | -16.2% | 0.06% | -90.1% |
| Q1 2019 | $299,000 | +0.7% | 7,947 | -8.1% | 0.64% | +1147.1% |
| Q4 2018 | $297,000 | -48.7% | 8,648 | -29.8% | 0.05% | -15.0% |
| Q3 2018 | $579,000 | -18.8% | 12,326 | -41.7% | 0.06% | -90.5% |
| Q2 2018 | $713,000 | -43.9% | 21,140 | -54.9% | 0.63% | -42.8% |
| Q1 2018 | $1,270,000 | +249.9% | 46,917 | +115.7% | 1.10% | +141.7% |
| Q4 2017 | $363,000 | -7.4% | 21,752 | +10.9% | 0.46% | +760.4% |
| Q3 2017 | $392,000 | +19.9% | 19,612 | +10.1% | 0.05% | +8.2% |
| Q2 2017 | $327,000 | +46.6% | 17,818 | -21.5% | 0.05% | +22.5% |
| Q1 2017 | $223,000 | -0.4% | 22,699 | +10.6% | 0.04% | -40.3% |
| Q4 2016 | $224,000 | -54.1% | 20,523 | -41.1% | 0.07% | -71.6% |
| Q3 2016 | $488,000 | +99.2% | 34,849 | 0.0% | 0.24% | +29.7% |
| Q2 2016 | $245,000 | +329.8% | 34,849 | +297.0% | 0.18% | +130.4% |
| Q1 2016 | $57,000 | – | 8,777 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
| RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
| GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
| SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
| Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
| ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
| Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
| Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
| Chubb Ltd | 8,180 | $387,000 | 1.10% |